In a patient with diabetic ketoacidosis and concurrent heart failure, how should a 50% dextrose (D50) infusion be administered?

D50 Administration in DKA with Heart Failure

In patients with DKA and concurrent heart failure, administer 10% dextrose infusion instead of D50 boluses, given slowly via central line or diluted for peripheral administration, with careful fluid balance monitoring to avoid volume overload. 1, 2

Key Management Principles

Avoid Concentrated Dextrose Boluses

• D50 (50% dextrose) should NOT be given as boluses in heart failure patients due to the risk of fluid overload and pulmonary edema 2
• The hypertonic nature of D50 can cause rapid fluid shifts and exacerbate congested states 2
• Standard DKA protocols calling for D50 must be modified in this population

Preferred Dextrose Administration Strategy

Use diluted dextrose solutions:

• Switch to 10% dextrose infusion when blood glucose falls to 150-200 mg/dL during DKA treatment 1
• Administer via central venous access if available, as concentrated dextrose should only be given centrally after suitable dilution 2
• For peripheral access, use lower concentrations (5-10% dextrose) infused slowly through large-bore veins 2

Insulin Management Adjustments

When glucose reaches target range:

• Reduce fixed-rate insulin infusion from 0.1 to 0.05 units/kg/h when glucose drops below 14 mmol/L (252 mg/dL) 1, 3
• Continue insulin infusion alongside dextrose-containing fluids until DKA resolves (anion gap normalizes, pH >7.3, bicarbonate >15 mEq/L) 1
• This approach maintains ketoacidosis resolution while preventing hypoglycemia without large dextrose boluses

Fluid Management in Heart Failure

Critical modifications for heart failure patients:

• Replace estimated fluid deficit more slowly than standard protocols—aim for 50% replacement over 12-24 hours rather than 8-12 hours 1
• Consider hemodynamic monitoring or vasopressor support if severe cardiac compromise exists 1
• Monitor for signs of fluid overload: increasing oxygen requirements, worsening respiratory status, elevated jugular venous pressure
• Total fluid administration should be restricted compared to standard DKA protocols

Monitoring Requirements

Enhanced surveillance needed:

• Check blood glucose every 1-2 hours (more frequently than standard 2-4 hour intervals) 1
• Monitor electrolytes, renal function, and venous pH every 2-4 hours 1
• Continuous cardiac monitoring for arrhythmias related to electrolyte shifts
• Strict intake/output monitoring with daily weights
• Watch for signs of pulmonary edema or worsening heart failure

Common Pitfalls to Avoid

1. Do not use standard D50 boluses (20-50 mL) as recommended for hypoglycemia—this delivers excessive fluid load 2
2. Do not delay dextrose addition when glucose reaches 200-250 mg/dL—this risks hypoglycemia and prolonged insulin infusion 1
3. Do not give aggressive fluid boluses (1-2L over 1 hour)—heart failure patients cannot tolerate rapid volume expansion 1
4. Do not stop insulin infusion prematurely—continue until metabolic acidosis fully resolves, using dextrose to prevent hypoglycemia 1

Practical Algorithm

1. Start standard DKA insulin protocol (0.1 units/kg/h IV) after confirming potassium >3.3 mEq/L 1
2. Give cautious fluid resuscitation (consider 250-500 mL boluses rather than 1-2L) 1
3. When glucose reaches 200-250 mg/dL:
   • Add 10% dextrose infusion at 75-125 mL/hr (adjust based on fluid tolerance)
   • Reduce insulin to 0.05 units/kg/h 1
4. Maintain glucose 150-200 mg/dL until DKA resolves 1
5. Transition to subcutaneous insulin only after metabolic resolution AND patient is hemodynamically stable 1

The maximum safe dextrose infusion rate is 0.5-0.8 g/kg/hour, with approximately 95% retention at the lower rate 2. In a 70 kg patient, this translates to roughly 35-56 g/hour, achievable with 350-560 mL/hour of 10% dextrose—but heart failure patients will require significantly slower rates (typically 75-150 mL/hour) balanced against insulin needs.